HUTCHMED (China) Financial Ratios
NASDAQ: HCMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HUTCHMED (China) ratio analysis
HUTCHMED (China) earned a net margin of 83.3% in FY 2025, up from 6.0% a year earlier. Gross margin was 38.7% compared with a median of 31.0% over the prior 5 years. Return on equity reached 36.9%, meaning HUTCHMED (China) generated 0.37 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.10 versus 0.14 the year before, and the current ratio was 4.96. At the end of FY 2025, HCM traded at 26.3 times earnings; across the 4 fiscal years shown, its year-end P/E ranged from 26.3 to 374.8, with a median of 109.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
HUTCHMED (China) financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 26.25 | 374.75 | 150.92 | — | — | — | — | — | — | 67.85 |
| Price / sales | 21.36 | 20.35 | 18.36 | 29.36 | 78.08 | 98.03 | 86.16 | 66.55 | 100.86 | 3.75 |
| Price / book | 9.46 | 16.87 | 21.06 | 20.51 | 28.18 | 46.16 | 61.30 | 36.63 | 52.69 | 4.40 |
| Gross margin | 38.7% | 44.6% | 54.1% | 27.0% | — | — | — | — | 29.6% | 31.0% |
| Operating margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% | -86.3% | -71.4% | -43.3% | -22.1% | -21.6% |
| Net margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.2% | -51.7% | -34.9% | -11.1% | 5.4% |
| Free cash flow margin | -14.4% | -2.8% | 22.3% | -71.6% | -62.0% | -30.7% | -43.7% | -18.3% | -5.8% | -6.4% |
| Return on equity (ROE) | 36.9% | 5.0% | 13.8% | -59.1% | -19.7% | -26.0% | -36.8% | -19.2% | -5.8% | 6.3% |
| Return on assets (ROA) | 26.1% | 3.0% | 7.9% | -35.1% | -14.2% | -17.4% | -22.8% | -14.1% | -4.5% | 3.4% |
| Debt / equity | 0.10 | 0.14 | 0.15 | 0.03 | 0.03 | 0.06 | 0.09 | 0.07 | 0.13 | 0.25 |
| Current ratio | 4.96 | 2.83 | 2.72 | 2.37 | 3.89 | 3.35 | 2.80 | 4.33 | 4.13 | 1.76 |
| Revenue growth | -13.0% | -24.8% | 96.5% | 19.7% | 56.2% | 11.3% | -4.3% | -11.2% | 11.6% | 21.3% |
| EPS growth | 1,200.0% | -66.7% | — | — | — | — | — | — | -315.0% | — |